Azurin interaction with the lipid raft components ganglioside GM-1 and caveolin-1 increases membrane fluidity and sensitivity to anti-cancer drugs

References

• Yamada T, Goto M, Punj V, et al. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. PNAS. 2002;99:14098–14103.
   PubMed Web of Science ®Google Scholar
• Taylor BN, Mehta RR, Yamada T, et al. Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Res. 2009;69:537–546.
   PubMed Web of Science ®Google Scholar
• Mehta RR, Yamada T, Taylor BN, et al. A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt. Angiogenesis. 2011;14:355–369.
   PubMed Web of Science ®Google Scholar
• Yamada T, Mehta RR, Lekmine F, et al. A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells. Mol Cancer Ther. 2009;8:2947–2958.
   PubMed Web of Science ®Google Scholar
• Bernardes N, Abreu S, Carvalho FA, et al. Modulation of membrane properties of lung cancer cells by azurin enhances the sensitivity to EGFR-targeted therapy and decreased β1 integrin-mediated adhesion. Cell Cycle [Internet]. 2016;15:1415–1424.
   PubMed Web of Science ®Google Scholar
• Yamada T, Fialho AM, Punj V, et al. Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. Cell Microbiol. 2005;7:1418–1431.
   PubMed Web of Science ®Google Scholar
• Warso MA, Richards JM, Mehta D, et al. A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours. Br J Cancer 2013 ;108:1061–1070.
   PubMed Web of Science ®Google Scholar
• Lulla RR, Goldman S, Yamada T, et al. Phase i trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A pediatric brain tumor consortium study. Neuro Oncol. 2016;18:1319–1325.
   PubMed Web of Science ®Google Scholar
• Mollinedo F, Gajate C. Lipid rafts as major platforms for signaling regulation in cancer. Adv Biol Regul. 2015;57:130–146.
   PubMedGoogle Scholar
• Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Caveolae and signalling in cancer. Nat Rev Cancer. 2015;15:225–237.
   PubMed Web of Science ®Google Scholar
• Lavie Y, Fiucci G, Liscovitch M. Upregulation of caveolin in multidrug resistant cancer cells: functional implications. Adv Drug Deliv Rev. 2001;49:317–323.
   PubMed Web of Science ®Google Scholar
• Quest FG, Lobos-González L, Nuñez S, et al. The caveolin-1 connection to cell death and survival. Curr Mol Med. 2013;13:266–281.
   PubMed Web of Science ®Google Scholar
• Bernardes N, Ribeiro AS, Abreu S, et al. The bacterial protein azurin impairs invasion and FAK/Src signaling in P-cadherin-overexpressing breast cancer models. PLoS One. 2013;19:e69023. Available from:.
   Google Scholar
• Bernardes N, Ribeiro AS, Abreu S, et al. High-throughput molecular profiling of a P-cadherin overexpressing breast cancer model reveals new targets for the anti-cancer bacterial protein azurin. Int J Biochem Cell Biol [Internet]. 2014 [cited 2014 Mar 15];50:1–9.
   PubMed Web of Science ®Google Scholar
• Pang H, Le PU, Nabi IR. Ganglioside GM1 levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatus. J Cell Sci. 2004;117:1421–1430.
   PubMed Web of Science ®Google Scholar
• Vihanto MM, Vindis C, Djonov V, et al. Caveolin-1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinase. J Cell Sci. 2006;119:2299–2309.
   PubMed Web of Science ®Google Scholar
• Bernardes N, Chakrabarty AM, Fialho AM. Engineering of bacterial strains and their products for cancer therapy. Appl Microbiol Biotechnol. 2013 ;97:5189–5199. Available from
   PubMed Web of Science ®Google Scholar
• Yanagisawa S, Banfield MJ, Dennison C. The role of hydrogen bonding at the active site of a cupredoxin : the Phe114Pro Azurin variant. Biochemistry. 2006;45:8812–8822.
   PubMed Web of Science ®Google Scholar
• Gaus K, Gratton E, Kable EPW, et al. Visualizing lipid structure and raft domains in living cells with two-photon microscopy. Proc Natl Acad Sci U S A. 2003;100:15554–15559.
   PubMed Web of Science ®Google Scholar
• Owen DM, Rentero C, Magenau A, et al. Quantitative imaging of membrane lipid order in cells and organisms. Nat Protoc. 2012;7:24–35.
   Web of Science ®Google Scholar
• del Pozo MA, Balasubramanian N, Alderson NB, et al. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat Cell Biol. 2005 ;7:901–908.
   PubMed Web of Science ®Google Scholar
• Norambuena A, Schwartz MA. Effects of integrin-mediated cell adhesion on plasma membrane lipid raft components and signaling. Mol Biol Cell. 2011 ;22:3456–3464.
   PubMed Web of Science ®Google Scholar
• Parasassi T, De Stasio G, Ravagnan G, et al. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of Laurdan fluorescence. Biophys J. 1991;60:179–189.
   PubMed Web of Science ®Google Scholar
• Parasassi T, Krasnowska EK. Laurdan and Prodan as polarity-sensitive fluorescent membrane probes. J Fluoresc. 1998;8:365–373.
   Web of Science ®Google Scholar
• Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327:46–50.
   PubMed Web of Science ®Google Scholar
• Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000;1:31–39.
   PubMed Web of Science ®Google Scholar
• Chaudhari A, Mahfouz M, Fialho AM, et al. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth. Biochemistry. 2007;46:1799–1810.
   PubMed Web of Science ®Google Scholar
• Micewicz E, Jung C, Schaue D, et al. Small Azurin derived peptide targets ephrin receptors for radiotherapy. Int J Pept Res Ther. 2011;17:247–257.
   Web of Science ®Google Scholar
• Ichikawa N, Iwabuchi K, Kurihara H, et al. Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth. J Cell Sci. 2009;122:289–299.
   PubMed Web of Science ®Google Scholar
• del Carmen Fernández-Alonso M, Díaz D, Berbis MÁ, et al. Protein-carbohydrate interactions studied by NMR: from molecular recognition to drug design. Curr Protein Pept Sci. 2012;13:816–830.
   PubMed Web of Science ®Google Scholar
• Yamamoto N, Matsubara T, Sato T, et al. Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid β-protein fibrillogenesis. Biochim Biophys Acta Biomembr. 2008;1778:2717–2726.
   PubMed Web of Science ®Google Scholar
• Wakabayashi M, Matsuzaki K. Ganglioside-induced amyloid formation by human islet amyloid polypeptide in lipid rafts. FEBS Lett. 2009;583:2854–2858.
   PubMed Web of Science ®Google Scholar
• Evangelisti E, Cascella R, Becatti M, et al. Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases. Sci Rep. 2016;6:32721.
   PubMed Web of Science ®Google Scholar
• Sezgin E, Levental I, Mayor S, et al. The mystery of membrane organization: composition, regulation and roles of lipid rafts. Nat Rev Mol Cell Biol. 2017;18:361–374.
   PubMed Web of Science ®Google Scholar
• Sengupta P, Baird B, Holowka D. Lipid rafts, fluid/fluid phase separation, and their relevance to plasma membrane structure and function. Semin Cell Dev Biol. 2007 ;18:583–590.
   PubMed Web of Science ®Google Scholar
• Peetla C, Vijayaraghavalu S, Labhasetwar V. Biophysics of cell membrane lipids in cancer drug resistance: implications for drug transport and drug delivery with nanoparticles. Adv Drug Deliv Rev. 2013 ;65:1686–1698.
   PubMed Web of Science ®Google Scholar
• Lee SW, Reimer CL, Oh P, et al. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene. 1998;16:1391–1397.
   PubMed Web of Science ®Google Scholar
• Shi Y, Tan S-H, Ng S, et al. Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy. Autophagy. 2015;11:769–784.
   PubMed Web of Science ®Google Scholar
• Logozzi M, De Milito A, Lugini L, et al. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients.PLoS One. 2009 ;4:e5219.
   PubMed Web of Science ®Google Scholar
• Chanvorachote P, Pongrakhananon V, Halim H. Caveolin-1 regulates metastatic behaviors of anoikis resistant lung cancer cells. Mol Cell Biochem. 2014;399:291–302.
   PubMed Web of Science ®Google Scholar
• Nam KH, Lee BL, Park JH, et al. Caveolin 1 expression correlates with poor prognosis and focal adhesion kinase expression in gastric cancer. Pathobiology. 2013;80:87–94.
   PubMed Web of Science ®Google Scholar
• Bourseau-Guilmain E, Menard JA, Lindqvist E, et al. Hypoxia regulates global membrane protein endocytosis through caveolin-1 in cancer cells. Nat Commun . 2016;7:11371.
   PubMed Web of Science ®Google Scholar
• Yamada T, Das Gupta TK, Beattie CW. P28-Mediated activation of p53 in G2-M phase of the cell cycle enhances the efficacy of DNA damaging and antimitotic chemotherapy. Cancer Res. 2016;76:2354–2365.
   PubMed Web of Science ®Google Scholar
• Alves AC, Magarkar A, Horta M, et al. Influence of doxorubicin on model cell membrane properties: insights from in vitro and in silico studies.Sci Rep. 2017;7:6343.
   PubMed Web of Science ®Google Scholar
• Colin D, Limagne E, Jeanningros S, et al. Endocytosis of resveratrol via lipid rafts and activation of downstream signaling pathways in cancer cells. Cancer Prev Res (Phila). 2011 ;4:1095–1106.
   PubMed Web of Science ®Google Scholar
• Lee EJ, Yun UJ, Koo KH, et al. Down-regulation of lipid raft-associated onco-proteins via cholesterol-dependent lipid raft internalization in docosahexaenoic acid-induced apoptosis. Biochim Biophys Acta - Mol Cell Biol Lipids. 2014;1841:190–203.
   PubMed Web of Science ®Google Scholar
• Escribá PV, Busquets X, Inokuchi J, et al. Membrane lipid therapy: modulation of the cell membrane composition and structure as a molecular base for drug discovery and new disease treatment. Prog Lipid Res. 2015;59:38–53.
   PubMed Web of Science ®Google Scholar
• Lakowicz JR. Principles of fluorescence spectroscopy. Joseph R. Lakowicz, editor. 3rd ed.; 2006, Springer US.
   Google Scholar